✦ LIBER ✦

590 Cost-effectiveness of peginterferon α-2a (40 kDa) plus ribavirin in treatment of chronic hepatitis C (CHC) in HIV-HCV co-infection

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

622 Cost-effectiveness of peginterferon

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Cost-effectiveness of peginterferon alfa

✍ John Hornberger; Francesca J. Torriani; Douglas T. Dieterich; Norbert Bräu; Mark 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 227 KB

PGI25 Cost Effectiveness of Boceprevir P

✍ M. Fonseca; G. Tannus; E. Parisi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Peginterferon α-2a (40 KD) plus ribaviri

✍ Makoto Kuboki; Shiro Iino; Tadao Okuno; Masao Omata; Kendo Kiyosawa; Hiromitsu K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

A comparison of cost-effectiveness of pe

✍ S.D. Sullivan; J. Green; K.K. Patel; A. Crtaxi; A. Alberti; G. Giuliani; C. De C 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 319 KB

PGI16 Cost Effectiveness of Boceprevir P

✍ M. Fonseca; V. Garran; G.T. Araujo 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB